Tag: Human Papillomavirus (HPV)
HPV Vaccination May Cut Risk for CIN2+ Recurrence
Effect estimate stronger for CIN2+ for disease related to HPV subtypes HPV 16 or HPV 18
HPV-Related Throat Cancer Outcomes in Men Vary by Race, Ethnicity
Cancer-specific mortality for HPV-related oropharyngeal cancer higher among non-Hispanic Black and Hispanic men than White men
2015 to 2020 Saw Increase in HPV Vaccination Rates Among Teens
Larger increases in coverage seen among boys than girls, with narrowing of coverage gap
Increasing Impact of HPV Vaccination Seen in the United States
Impact on 4vHPV-type prevalence in 2015 to 2018 for 14- to 24-year-old females 90 percent among vaccinated, 74 percent among unvaccinated
HPV-Associated Cancer Incidence Starting to Increase
Cervical cancer incidence plateaued in highest-income counties, increased in lowest-income counties in recent years
Incidence of Oropharyngeal Cancer Projected to Rise in U.S. Men
Under a status quo scenario based on current levels of HPV vaccination, 792,000 OPC cases in men would be prevented by the year 2100
Cervical Cancer Deaths Down Following HPV Vaccine Introduction
Reductions in cervical cancer incidence, mortality in the U.S. greater for those aged 15 to 24 years than those aged 25 to 29, 30 to 39 years
HPV Vaccine Will Have Modest Impact on Oropharynx Cancer Incidence by 2045
However, reductions in oropharynx cancer incidence should be seen among young and middle-aged adults
Human Papillomavirus Infection Tied to Preterm Birth Risk
Risk increased for both persistent and placental infection and for both spontaneous and all preterm births
Parents Increasingly Cite Safety Concerns in HPV Vaccine Refusal
Despite 79.9 percent increase in parent-reported safety concerns, there was a drop in HPV vaccine-related reported adverse reactions
